Amphastar P

AMPH · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

47 USD

Margin of Safety

+58.5 %

Rating

BEOBACHTEN

AMPHASTAR PHARMACEUTICALS Amphastar Pharmaceuticals develops, manufactures, and distributes specialty and generic injectables as well as insulin products, earning primarily through regulatory-protected niche products with integrated active pharmaceutical ingredient (API) manufacturing.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.